Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachael M Hunter

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|November 5, 2013
Injectable heroin - effective treatment for opiate misusers, but is it cost-effective?Rachael M Hunter, Sherife Hasan
Plos One|March 2, 2017
Multi-arm Cost-Effectiveness Analysis (CEA) comparing different durations of adjuvant trastuzumab in early breast cancer, from the English NHS payer perspectiveCaroline S Clarke, Rachael M Hunter, Ian Shemilt, et al.
Value in Health Regional Issues|February 18, 2026
Economic Evaluation of Breast Cancer Screening in China: A Systematic Review of Costs and Cost-EffectivenessAnqi Liu, Keyi Li, Jiunn Wang, et al.
Plos One|February 27, 2019
Healthcare resource utilisation and costs of agitation in people with dementia living in care homes in England - The Managing Agitation and Raising QUality of LifE in Dementia (MARQUE) studyMonica Panca, Gill Livingston, Julie Barber, et al.
The Lancet. Oncology|May 2, 2024
Cancer incidence, treatment, and survival in the prison population compared with the general population in England: a population-based, matched cohort studyMargreet Lüchtenborg, Jennie Huynh, Jo Armes, et al.
Lancet (London, England)|April 6, 2019
Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trialKate E Duhig, Jenny Myers, Paul T Seed, et al.
Epilepsia|June 5, 2015
The health, education, and social care costs of school-aged children with active epilepsy: A population-based studyRachael M Hunter, Colin Reilly, Patricia Atkinson, et al.
Trials|September 2, 2022
Placental growth fActor Repeat sampling for Reduction of adverse perinatal Outcomes in women with suspecTed pre-eclampsia: study protocol for a randomised controlled trial (PARROT-2)Alice Hurrell, Jenie Sparkes, Kate Duhig, et al.
Medicina (Kaunas, Lithuania)|April 30, 2021
The Role of Prevention in Reducing the Economic Impact of ME/CFS in Europe: A Report from the Socioeconomics Working Group of the European Network on ME/CFS (EUROMENE)Derek F H Pheby, Diana Araja, Uldis Berkis, et al.
Healthcare (Basel, Switzerland)|April 11, 2020
The Development of a Consistent Europe-Wide Approach to Investigating the Economic Impact of Myalgic Encephalomyelitis (ME/CFS): A Report from the European Network on ME/CFS (EUROMENE)Derek F H Pheby, Diana Araja, Uldis Berkis, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
The British Journal of Psychiatry : the Journal of Mental Science|November 5, 2013
Injectable heroin - effective treatment for opiate misusers, but is it cost-effective?Rachael M Hunter, Sherife Hasan
Plos One|March 2, 2017
Multi-arm Cost-Effectiveness Analysis (CEA) comparing different durations of adjuvant trastuzumab in early breast cancer, from the English NHS payer perspectiveCaroline S Clarke, Rachael M Hunter, Ian Shemilt, et al.
Value in Health Regional Issues|February 18, 2026
Economic Evaluation of Breast Cancer Screening in China: A Systematic Review of Costs and Cost-EffectivenessAnqi Liu, Keyi Li, Jiunn Wang, et al.
Plos One|February 27, 2019
Healthcare resource utilisation and costs of agitation in people with dementia living in care homes in England - The Managing Agitation and Raising QUality of LifE in Dementia (MARQUE) studyMonica Panca, Gill Livingston, Julie Barber, et al.
The Lancet. Oncology|May 2, 2024
Cancer incidence, treatment, and survival in the prison population compared with the general population in England: a population-based, matched cohort studyMargreet Lüchtenborg, Jennie Huynh, Jo Armes, et al.
Lancet (London, England)|April 6, 2019
Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trialKate E Duhig, Jenny Myers, Paul T Seed, et al.
Epilepsia|June 5, 2015
The health, education, and social care costs of school-aged children with active epilepsy: A population-based studyRachael M Hunter, Colin Reilly, Patricia Atkinson, et al.
Trials|September 2, 2022
Placental growth fActor Repeat sampling for Reduction of adverse perinatal Outcomes in women with suspecTed pre-eclampsia: study protocol for a randomised controlled trial (PARROT-2)Alice Hurrell, Jenie Sparkes, Kate Duhig, et al.
Medicina (Kaunas, Lithuania)|April 30, 2021
The Role of Prevention in Reducing the Economic Impact of ME/CFS in Europe: A Report from the Socioeconomics Working Group of the European Network on ME/CFS (EUROMENE)Derek F H Pheby, Diana Araja, Uldis Berkis, et al.
Healthcare (Basel, Switzerland)|April 11, 2020
The Development of a Consistent Europe-Wide Approach to Investigating the Economic Impact of Myalgic Encephalomyelitis (ME/CFS): A Report from the European Network on ME/CFS (EUROMENE)Derek F H Pheby, Diana Araja, Uldis Berkis, et al.
Pageof 4